Connecticut Plastics, Inc provides plastic machined products to the medical device industry. With a large portion of the company’s manufacturing in this sector, health care legislative reform is of interest to us.
In July 2009, European Plastics News reported that some medical device manufacturers are expecting growth of about 6% this year. Along the same line, Scott Burns, editor of Morningstar ETF Investor, stated in August 2009 that investors would be smart to have stocks from medical device OEMs in their portfolios. His rationale is based on the fact that medical device manufacturers generally are dealing directly with individual hospitals and not the larger health care system. This according to Burns, “gives the manufacturers a bargaining advantage because there are only a limited number of device makers.”
Connecticut Plastics, Inc. believes that medical device manufacturers will not be adversely affected by changes in health care legislation, no matter what form it takes. While Connecticut Plastics, Inc. still feels it is important to diversify our manufacturing capabilities, it is promising that health care reform will have minimal impact on medical device OEMs. Tom Rohlfs, VP of Connecticut Plastics, states, “We hope that health reform legislation strengthens our nation and our company. It fits in with our future plans of growth.”
For more information on precision plastic machined components, please visit our website at www.connecticutplastics.com
